down arrow

Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001808
CNY
46.37
0.52 (1.13%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. stock-summary
stock-summary
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,174 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,551 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 24,895 Million (Large Cap)

stock-summary
P/E

7.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.93%

stock-summary
Debt Equity

-0.58

stock-summary
Return on Equity

39.69%

stock-summary
Price to Book

2.83

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."